The cardiovascular actions of thalicarpine.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001060:Aporphines / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology; D002302:Cardiac Output / Q000187:drug effects; D004155:Diphenhydramine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004562:Electrocardiography; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007546:Isoquinolines / Q000494:pharmacology*; D008251:Macaca; D010477:Perfusion; D011433:Propranolol / Q000494:pharmacology; D012119:Respiration / Q000187:drug effects; D013997:Time Factors; D014655:Vascular Resistance / Q000187:drug effects
D000970:Antineoplastic Agents; D001060:Aporphines; D006584:Hexamethonium Compounds; D007546:Isoquinolines; D001285:Atropine; D004155:Diphenhydramine; D011433:Propranolol